# the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC83518 Tablets

> **NCT04667429** · PHASE1 · COMPLETED · sponsor: **Sunshine Lake Pharma Co., Ltd.** · enrollment: 57 (actual)

## Conditions studied

- Insomnia

## Interventions

- **OTHER:** Food
- **DRUG:** HEC83518
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT04667429
- **Lead sponsor:** Sunshine Lake Pharma Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-18
- **Primary completion:** 2021-07-09
- **Final completion:** 2021-07-09
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04667429

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04667429, "the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC83518 Tablets". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04667429. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*